Skip to content

Relation Between Aldosterone and Cardiac Remodeling After Myocardial Infarction

Multiparametric Study of Cardiac Remodeling After Myocardial Infarction Revascularized in Acute Phase : Relation With the Serum Concentrations in Aldosterone

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01109225
Acronym
REMI
Enrollment
145
Registered
2010-04-23
Start date
2010-04-27
Completion date
2020-02-04
Last updated
2021-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

aldosterone, myocardial infarction, cardiac remodeling

Brief summary

This study aims to determine whether aldosterone blood levels are predictive of cardiac remodeling at 6 months following myocardial infarction with ST elevation (STEMI), independently of conventional predictive factors (size of myocardial infarction, age, hypertension, etc.) in revascularized patients during the acute phase of MI.

Detailed description

After myocardial infarction, the evolution toward cardiac failure is generally linked to a progressive worsening of cardiac dysfunction and remodeling. Cardiac remodeling is largely the consequence of myocardial injury due to myocardial infarction, although other parameters including age, arterial hypertension, etc. may also represent important predictors. Aldosterone blood levels measured within the first hours of admission for myocardial infarction is associated with increased rates of adverse outcomes. Aldosterone acts on wound healing and fibrosis processes in the myocardium as well as on systemic volemia.

Interventions

BIOLOGICALblood sample
PROCEDUREMRI
PROCEDUREechocardiography
BIOLOGICALurine sample
PROCEDUREvascular check

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Man or woman hospitalized for a first myocardial infarction with known shift of the segment ST revascularized in acute phase by primary angioplasty and dated less than 4 days * Patient presenting a stable clinical state * Patient presenting a regular sinusal cardiac rhythm * Patient having an age ≥ 18 years

Exclusion criteria

* Counter-indication with examination MRI * Severe claustrophobia * Antecedent of over-sensitiveness to gadolinium salts * Nonischaemic Cardiopathy * Cardiac surgery planed in the 6 months * Women into old to procreate without effective contraception

Design outcomes

Primary

MeasureTime frame
Cardiac remodeling within 6 months of myocardial infarction as defined as the change in left ventricle volumes (increase of more than 20 % of the diastolic volume of the left ventricle)from initial assessment to 6 months

Secondary

MeasureTime frame
Vascular and cardiac parameters measured during the initial assesment and at 6 months (both functional and structural - by echocardiography or MRI)from initial assessment to 6 months
Long-term cardiac remodeling measured by echocardiography at 3 to 9 years of initial enrollmentat 3 to 9 years of initial enrollment

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026